Historique de carrière de Mary Lucus
Anciens postes connus de Mary Lucus
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SELECTIS HEALTH, INC. | Comptroller/Controller/Auditor | 01/04/2021 | 05/04/2023 |
| Directeur Financier/CFO | 04/03/2022 | 05/04/2023 | |
| Secrétaire Général | 31/10/2022 | 05/04/2023 | |
| NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Formation de Mary Lucus
| San Diego State University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
Sectorielle
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SELECTIS HEALTH, INC. | Finance |
| Entreprise privées | 1 |
|---|---|
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. | Health Technology |
- Bourse
- Insiders
- Mary Lucus
- Expérience
